Icon

ELOXATIN (nda021492)- (50MG/VIAL,100MG/VIAL)

OXALIPLATIN SANOFI AVENTIS US
50MG/VIAL,100MG/VIAL
No No
2017-Feb-09 Expired
None None
None No
ELOXATIN is a platinum-based drug used in combination with infusional fluorouracil and leucovorin, which is indicated for:  adjuvant treatment of stage III colon cancer in patients who have undergone complete resection of the primary tumor.  treatment of advanced colorectal cancer.
4 0 3
Total Other Developers None
Drugs with Suitability No
50MG/VIAL ** ** - - -
100MG/VIAL ** ** - - -
NDA Sales Available Total Generic Sales Available
No 1
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ******* ****** ******-****** *** *********** *** ********* ****. **. **, ******** *, *********, ******, ******* (***) ***
****** **** ***** ****** **** ************** (******) **., ***. *********** **.***-*, ****** ******, ******** ****-**** ****, ******, ****** ******, ***** (***) ***
****** ***** ****** *** ***** ****** ******* *********** **** * & **** **, ***** *, ***** *, ************* ******* ******** **** (**** ), *******, *************, ****** ******* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.